Clinical Trial

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock. Researchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Trial Details
NCT Number NCT07012863
Lead Sponsor Vastra Gotaland Region
Conditions Bleeding, Aortic Rupture, Gastrointestinal Hemorrhage, Obstetric Bleeding, Blunt Injury, Penetrating Injury
Enrollment 650 participants
Start Date 2026-01-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-17